SCHEMBL16218015

SCHEMBL16218015

C=CC(=O)C(Cc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
MDM2 Q00987 1/20 0.53
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
CPA3 P15088 3/20 0.47
CPA1 P15085 2/20 0.47
FOLH1 Q04609 1/20 0.47
CPB1 P15086 1/20 0.47
CPB2 Q96IY4 1/20 0.47
SRR Q9GZT4 2/20 0.46
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
MME P08473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405183 0.83 CTSB (0.48) CYP1A2MDM2MMP8
SCHEMBL392827 0.81 CYP1A2 (0.70) CYP1A2MDM2ALPIPKMPTGS1
SCHEMBL28141249 0.81 CYP1A2 (0.48) CYP1A2MDM2ALPIPKMPTGS1
SCHEMBL4826237 0.81 CYP1A2 (0.53) CYP1A2MDM2ALPIPKMPTGS1
SCHEMBL27418403 0.79 CYP1A2 (0.47) CYP1A2MDM2ALPIPKMPTGS1
SCHEMBL2600708 0.79 HPGD (0.51) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL13367286 0.79 SLC7A5 (0.63) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL11499279 0.79 SLC7A5 (0.63) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL18383090 0.79 HPGD (0.51) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL28377626 0.79 CYP1A2 (0.67) CYP1A2MDM2ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108089380-A A kind of single side bipolar electrode and a kind of method of electric responsive material surface configuration 华南师范大学 2018-05-29 CN disclosed
US-9498420-B2 Cosmetic compositions and methods for inhibiting melanin synthesis THE PROCTER & GAMBLE COMPANY (US) 2016-11-22 US disclosed
US-20140328775-A1 Cosmetic Compositions and Methods For Inhibiting Melanin Synthesis THE PROCTER & GAMBLE COMPANY (US) 2014-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140328775-A1 Cosmetic Compositions and Methods For Inhibiting Melanin Synthesis TYR, MITF, DBH CYP1A2 1725/4885MDM2 4350/4885ALPI 1631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.